WallStreetZenWallStreetZen

AnalystsJennifer Kim
Jennifer Kim's Stock Forecasts

Analyst Ranking
Bottom 8%
#4094 out of 4416 analysts
Average Return
-34.1%
Win Rate
15%5 out of 34
Risk vs Reward
Poor
Good

Jennifer Kim's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Belite Bio IncBLTE
+74.56%$24.10$42.07
2023-07-27 -
2023-11-30
Strong Buy
Insmed IncINSM
+46.75%$17.07$25.05
2022-10-24 -
2023-10-24
Strong Buy
Checkpoint Therapeutics IncCKPT
+31.68%$2.02$2.66
2023-08-14 -
2023-11-30
Strong Buy
Insmed IncINSM
+24.66%$20.07$25.02
2023-02-23 -
2023-11-30
Strong Buy
Poseida Therapeutics IncPSTX
+18.14%$2.26$2.67
2023-10-09 -
2023-11-30
Strong Buy

Jennifer Kim Analyst Color

Get additional color on Jennifer Kim's coverage of popular stocks

Jennifer Kim's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Poseida Therapeutics IncPSTX
2Strong Buy$14.00+424.34%Reiterates
2 months ago
Insmed IncINSM
5Strong Buy$54.00+115.83%Maintains
2 months ago
Eyepoint Pharmaceuticals IncEYPT
4Strong Buy$31.00+396.00%Reiterates
3 months ago
Ocugen IncOCGN
2Strong Buy$2.00+416.80%Maintains
3 months ago
Fortress Biotech IncFBIO
2Strong Buy$75.00+3,687.88%Reiterates
4 months ago
Checkpoint Therapeutics IncCKPT
4Strong Buy$14.00+426.32%Maintains
4 months ago
Belite Bio IncBLTE
1Strong Buy$43.00+2.21%Initiates Coverage On
4 months ago
Lipocine IncLPCN
2Strong Buy$33.00+1,269.29%Reiterates
4 months ago
Proqr Therapeutics NvPRQR
2Strong Buy$4.50+190.32%Maintains
6 months ago
Novan IncNOVNQ
2Strong Buy$8.00+8,410.64%Reiterates
8 months ago
Allakos IncALLK
3Strong Buy$7.00+215.32%Reiterates
9 months ago
Precigen IncPGEN
2Strong Buy$10.00+792.86%Maintains
10 months ago
Aytu Biopharma IncAYTU
2Strong Buy$100.00N/AMaintains
2 years ago
Calcimedica IncCALC
1Strong Buy$4.00N/AMaintains
2 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.